How is next-generation protein sequencing democratizing protein sequencing?

In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.

FDA defends increased use of guidance in new report to Congress

The FDA is defending its increased use of non-binding guidance documents rather than legally-enforceable rulemakings, arguing that guidance can better keep pace with the latest

December 3, 2024

‘Clinical trial in a dish’ for Alzheimer’s disease

Axol Bioscience Ltd., a pluripotent stem cell technology provider for drug discovery, has signed an agreement with StrataStem to access and commercialize its collection of

June 13, 2023

Neurologic Conditions Now Leading Cause of Disability Worldwide

Disorders affecting the nervous system were the leading cause of ill health and disability globally, affecting 3.4 billion people worldwide, a systematic analysis for the

March 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.